You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Bayer buys Calif. birth control firm

FRANKFURT — German drug company Bayer AG says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it ­offers.

Bayer said Monday it would launch a public offer to pay $31 per share for all the stock in Conceptus Inc., which is based in Mountain View.

Continue reading below

Conceptus makes Essure, an irreversible birth control method in which small metal and polyester coils are inserted to block a woman’s fallopian tubes. The procedure can be done in 10 minutes in a doctor’s office.

Bayer already markets birth control pills and intrauterine devices. Chief executive Marijn Dekkers said that the deal represented a ‘‘strategic bolt-on acquisition’’ and that it was an ‘‘excellent fit in the United States, the world’s most important health care market.’’

Conceptus chief executive D. Keith Grossman was quoted in a Bayer statement as saying Essure ‘‘will benefit in new markets from Bayer’s global presence.’’

The deal is subject to approval by antitrust authorities and could be completed by midyear.

Conceptus employs about 300 people. Bayer has about 112,000 employees and is based in Leverkusen, ­Germany.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.